According to the latest rankings published by CEOWORLD magazine on March 23, 2023, AstraZeneca PLC is the most valuable company in the United Kingdom with a market capitalization of
$208 billion. This means that AstraZeneca has surpassed Microsoft Corporation, which holds the second position with a market cap of $195 billion. HSBC Holdings PLC comes in at third place, with a market capitalization of $136 billion, followed by Unilever PLC with a market cap of $129 billion, and BP PLC with a market capitalization of $110 billion.
Market capitalization is a crucial metric used to compare the value of companies in terms of trading opportunities. It takes into account the current stock price and the total number of outstanding shares of a company. The rankings are based on the latest market capitalization data provided by the New York Stock Exchange, the London Stock Exchange, or other leading global stock exchanges.
Rio Tinto PLC occupies the sixth position in the ranking with a market capitalization of $109 billion, while Diageo PLC is in the seventh position with a market cap of $99 billion. British American Tobacco PLC is in eighth place with a market capitalization of $81 billion. GSK PLC ranks ninth with a market cap of $70 billion, while Glencore PLC comes in at the tenth position with a market capitalization of $69 billion. AstraZeneca's position as the most valuable company in the United Kingdom is a significant achievement for the pharmaceutical giant. The company has a strong portfolio of drugs and has been investing heavily in research and development to maintain its competitive edge. The company's recent success with the COVID-19 vaccine has also helped to boost its reputation and stock price.
Ranked: Top UK companies ranked by market capitalization as of March 23, 2023
- ASTRAZENECA PLC: $208 billion
- SHELL PLC: $195 billion
- HSBC HOLDINGS PLC: $136 billion
- UNILEVER PLC: $129 billion
- BP PLC: $110 billion
- RIO TINTO PLC: $109 billion
- DIAGEO PLC: $99 billion
- BRITISH AMERICAN TOBACCO PLC: $81 billion
- GSK PLC: $70 billion
- GLENCORE PLC: $69 billion.
Photo by D Wells, Wikimedia commons.